> ## Content Index
> Fetch the complete content index at: https://news.arxhq.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Nuvectis Pharma completes $100 million public offering
- URL: https://news.arxhq.com/nuvectis-100m-offering/
- Published: 2026-07-01T16:00:00.000Z
- Updated: 2026-09-08T09:54:22.000Z
- Description: Nasdaq: NVCT prices 5,000,000 shares at $20.00. Proceeds to advance NXP100, NXP200 and NXP900.
- Author: Arx Staff
- Tags: Client news, Deals

Congratulations to Nuvectis Pharma (NASDAQ: NVCT) on completing a $100 million public offering of common stock.

The company priced 5,000,000 shares at $20.00 per share. Cantor acted as sole bookrunner, with H.C. Wainwright, Laidlaw, Lucid Capital Markets, Maxim Group, Roth Capital Partners and Titan Partners as co-managers.

Proceeds are expected to support continued development of NXP100, NXP200, NXP900 and future product candidates — a meaningful raise at an important moment in the company’s evolution, following its strategic portfolio expansion with Haisco.

[Read the full release](https://www.globenewswire.com/news-release/2026/06/30/3319364/0/en/Nuvectis-Pharma-Announces-Pricing-of-100-Million-Public-Offering-of-Common-Stock.html?ref=news.arxhq.com)